Effect of anti-hypertensive drugs on choroid thickness in patients with essential hypertension

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053433

Enrollment

Unknown

Registered

2021-11-21

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

experimental group:anti-hypertensive drugs

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. The age ranged from 18 to 45 years old; 2. Patients with initial essential hypertension: systolic blood pressure>=140mmHg and/or diastolic blood pressure >= 90mmHg 3. The diopter is between ± 1.50D.

Exclusion criteria

Exclusion criteria: 1. Patients with other organic changes in the eyes, such as keratoconus, amblyopia, strabismus, cataract, glucoma, and etc; 2. Patients with astigmatism > 150 degree; 3. Patients with other diseases that affect the development of the eye, such as diabetes and other nutrition related diseases,serious heart, liver and kidney diseases, and etc.

Design outcomes

Primary

Measure	Time frame
refractive state;choriodal thickness;corneal curvature;plasma ET-1;axial length;	—

Countries

China

Contacts

Public ContactZhu Xiaowei

Zhongshan People's Hospital

404164015@qq.com+86 13543812046

Outcome results